Introduction: Mucoepidermoid carcinoma (MEC) of the upper aerodigestive tract (UADT) is an uncommon malignancy, with limited literature available on its clinical and pathologic characteristics. Here, we describe the behavior of MEC of the UADT including pathologic characteristics and predictors of nodal metastasis. Methods: Retrospective cohort study of patients with MEC of the UADT treated at an academic medical center from January 2008 to May 2018. Data was collected about demographics and tumor characteristics including clinical and histological data. The two-tailed Student t test and χ2 analysis were performed to assess for predictors of nodal metastasis. Results: We identified 44 patients with minor salivary gland MEC of the oral cavity (OC) and oropharynx (OP). All patients were treated with primary site surgery. The primary site was the OC in 25 patients (57%) and OP in 19 (43%). Low-grade histology was seen in 27 specimens (61.4%), intermediate histology in 9 specimens (20.5%), and high-grade histology in 8 specimens (18.2%). Perineural invasion was noted in 10 specimens (22.7%). Neck dissection was performed in 17 patients (39%), with pathologically positive nodes found in 9 (20.5%). Notably, 5 of the 9 positive nodal specimens were found in clinically node-negative necks. Pathologically positive cervical lymph nodes were significantly associated with the OP as the primary site (p = 0.0005), perineural invasion (p = 0.012), lymphovascular invasion (p < 0.001), and high-grade histology (p = 0.004) in the primary specimen. Discussion: MEC of the UADT is an uncommon malignancy. Our findings suggest elective neck dissection should be considered with perineural and lymphovascular invasion, high-grade tumor, and the OP as the primary site.

1.
Ellis
GL
,
Auclair
PL
.
Tumors of the salivary glands
.
Volume 17
.
Washington (D.C)
:
Armed Forces Inst. of Pathology
;
1996
., http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007288586&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
2.
Goode
RK
,
Auclair
PL
,
Ellis
GL
.
Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria
.
Cancer
.
1998
Apr
;
82
(
7
):
1217
24
.
[PubMed]
0008-543X
3.
McHugh
JB
,
Visscher
DW
,
Barnes
EL
.
Update on selected salivary gland neoplasms
.
Arch Pathol Lab Med
.
2009
Nov
;
133
(
11
):
1763
74
.
[PubMed]
1543-2165
4.
Vander Poorten
V
,
Hunt
J
,
Bradley
PJ
,
Haigentz
M
 Jr
,
Rinaldo
A
,
Mendenhall
WM
, et al.
Recent trends in the management of minor salivary gland carcinoma
.
Head Neck
.
2014
Mar
;
36
(
3
):
444
55
.
[PubMed]
1043-3074
5.
Ellis
MA
,
Graboyes
EM
,
Day
TA
,
Neskey
DM
.
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database
.
Oral Oncol
.
2017
Sep
;
72
:
174
8
.
[PubMed]
1368-8375
6.
Ozawa
H
,
Tomita
T
,
Sakamoto
K
,
Tagawa
T
,
Fujii
R
,
Kanzaki
S
, et al.
Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients
.
Jpn J Clin Oncol
.
2008
Jun
;
38
(
6
):
414
8
.
[PubMed]
0368-2811
7.
Triantafillidou
K
,
Dimitrakopoulos
J
,
Iordanidis
F
,
Koufogiannis
D
.
Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature
.
Oral Dis
.
2006
Jul
;
12
(
4
):
364
70
.
[PubMed]
1354-523X
8.
Rapidis
AD
,
Givalos
N
,
Gakiopoulou
H
,
Stavrianos
SD
,
Faratzis
G
,
Lagogiannis
GA
, et al.
Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients
.
Oral Oncol
.
2007
Feb
;
43
(
2
):
130
6
.
[PubMed]
1368-8375
9.
Liu
S
,
Ow
A
,
Ruan
M
,
Yang
W
,
Zhang
C
,
Wang
L
, et al.
Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population
.
Int J Oral Maxillofac Surg
.
2014
Jun
;
43
(
6
):
667
73
.
[PubMed]
0901-5027
10.
Byrd
SA
,
Spector
ME
,
Carey
TE
,
Bradford
CR
,
McHugh
JB
.
Predictors of recurrence and survival for head and neck mucoepidermoid carcinoma
.
Otolaryngol Head Neck Surg
.
2013
Sep
;
149
(
3
):
402
8
.
[PubMed]
0194-5998
11.
Chen
MM
,
Roman
SA
,
Sosa
JA
,
Judson
BL
.
Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients
.
Head Neck
.
2014
Feb
;
36
(
2
):
158
63
.
[PubMed]
1043-3074
12.
McHugh
CH
,
Roberts
DB
,
El-Naggar
AK
,
Hanna
EY
,
Garden
AS
,
Kies
MS
, et al.
Prognostic factors in mucoepidermoid carcinoma of the salivary glands
.
Cancer
.
2012
Aug
;
118
(
16
):
3928
36
.
[PubMed]
0008-543X
13.
Vander Poorten
VL
,
Balm
AJ
,
Hilgers
FJ
,
Tan
IB
,
Keus
RB
,
Hart
AA
.
Stage as major long term outcome predictor in minor salivary gland carcinoma
.
Cancer
.
2000
Sep
;
89
(
6
):
1195
204
.
[PubMed]
0008-543X
14.
Xiao
CC
,
Zhan
KY
,
White-Gilbertson
SJ
,
Day
TA
.
Predictors of nodal metastasis in parotid malignancies
.
Otolaryngol Head Neck Surg
.
2016
Jan
;
154
(
1
):
121
30
.
[PubMed]
0194-5998
15.
Brandwein
MS
,
Ivanov
K
,
Wallace
DI
,
Hille
JJ
,
Wang
B
,
Fahmy
A
, et al.
Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading
.
Am J Surg Pathol
.
2001
Jul
;
25
(
7
):
835
45
.
[PubMed]
0147-5185
16.
Guzzo
M
,
Andreola
S
,
Sirizzotti
G
,
Cantu
G
.
Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan
.
Ann Surg Oncol
.
2002
Aug
;
9
(
7
):
688
95
.
[PubMed]
1068-9265
17.
Evans
HL
.
Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading
.
Am J Clin Pathol
.
1984
Jun
;
81
(
6
):
696
701
.
[PubMed]
0002-9173
18.
Spiro
RH
,
Huvos
AG
,
Berk
R
,
Strong
EW
.
Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases
.
Am J Surg
.
1978
Oct
;
136
(
4
):
461
8
.
[PubMed]
0002-9610
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.